Clinical Trial Update: Efficacy of 300 mg Ibuprofen Prolonged-Release Tablets for the Treatment of Pain After Surgical Removal of Impacted Third Molars [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating 300 mg ibuprofen prolonged-release tablets for managing pain after surgical removal of impacted third molars; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Dental Pain

Drugs mentioned

• Ibuprofen Prolonged-Release 300 mg (ibuprofen)

Snippet

Sponsor: Reckitt Benckiser Healthcare (UK) Limited | Conditions: Pain | Phase 3 | Status: COMPLETED | Results posted: 2024-06-03